NFkappaB gene silencing inhibits wear particles-induced inflammatory osteolysis

Medical Hypotheses
Tao Cheng, Xianlong Zhang

Abstract

Wear particles-induced periprosthetic osteolysis involved in proinflammatory cytokine production and osteoclastogenesis, is the major cause of prosthetic join implant loosening. Recent advances in our understanding of cellular and molecular mechanisms of periprosthetic osteolysis have highlighted cytokine release and osteoclast function controlled by numerous intracellular signaling pathway, one of which is nuclear factor kappa B (NFkappaB). Direct inhibition of NFkappaB is an efficient therapy to block bone erosion associated with inflammatory arthritis. There are no approved nonoperative treatments for periprosthetic osteolysis. Gene therapy, however, offers novel possibilities. As the implant interface cells are located in the closed joint space, intra-articular injection of siRNA (small interfering RNA) is accessible as local administration to avoid systemic side effect. We postulate that local administration of siRNA for NFkappaB could inhibit wear particles-induced inflammatory osteolysis. In our opinion, this gene therapy seems to hold interesting future prospects for effective therapeutic interventions in humans.

References

Oct 14, 2003·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·S AbbasY Abu-Amer
Jan 16, 2004·Gene Therapy·P H Wooley, E M Schwarz
May 18, 2006·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·John C ClohisyYousef Abu-Amer
Mar 8, 2007·Annals of the New York Academy of Sciences·Roberta PivaRoberto Gambari
Jul 20, 2007·Arthritis Research & Therapy·Yousef Abu-AmerJohn C Clohisy

❮ Previous
Next ❯

Citations

Nov 10, 2010·Expert Opinion on Biological Therapy·Qin ShiJulio C Fernandes
Nov 24, 2020·Journal of Inflammation Research·Stuart B Goodman, Masahiro Maruyama

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis